Studies on metabolic disorders, notably diabetes, is highly internationally recognized and one of Umeå University’s strong profile areas in molecular medicine.

This builds on the long and strong tradition in molecular biology at Umeå University that, together with the unique biobank and patient registers established at Umeå University together with the County Council, have enabled a successful integration of basic, clinical, and applied science within the field.

Professor Helena Edlund
Image Mattias Pettersson

Helena Edlund is a leading diabetes researcher unravelling the molecular mechanisms underlying the development of Type 2 diabetes. For an example of diabetes/metabolism research conducted at Umeå University, read more about her research here and below

"Umeå University offers a strong research environment and a multitude of available infrastructures,” says Professor Helena Edlund. “Together with the national network of Wallenberg centres, this provides an ideal setting and unique opportunity for young, ambitious researchers who want to start their own independent line of research and build a competitive research group.”

Research within metabolic diseases/diabetes is conducted at the following departments:

Umeå Centre for Molecular Medicine
Department of Biobank Research
Department of Radiation Sciences
Department of Medical Biosciences
Department of Public Health and Clinical Medicine

Leading the fight against obesity-related diabetes

Diabetes research continues to be one of Umeå University’s internationally recognized profile areas. This is in large part due to the research performed by Professor Helena Edlund.

Together with her research group, Edlund focuses on unravelling molecular mechanisms underlying the development of type 2 diabetes. Edlund’s research has contributed significantly to our understanding of mechanisms underlying the formation and function of insulin-producing cells. The research also helps us understand how obesity and metabolic dysfunction affect insulin-producing beta cells, and how this in turn contributes to the global health problem that is type 2 diabetes.

http://horizon2020projects.com/publications  Issue 10, pages 48-49

In the Spotlight at Umeå University

Expanded understanding of promising blood fat-lowering protein

Expanded understanding of promising blood fat-lowering protein

New research on the blood lipid-lowering protein FGF21 shows how it redistributes fatty acids by two distinct mechanisms. The discovery could lead to improved pharmaceutical treatment for type 2 diabetes and other obesity-related diseases. This according to a new study published in the journal Cell Metabolism. Read more